{"id":3883,"date":"2021-03-10T14:56:48","date_gmt":"2021-03-10T14:56:48","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3883"},"modified":"2021-03-10T14:56:52","modified_gmt":"2021-03-10T14:56:52","slug":"cubas-abdala-vaccine-to-begin-phase-iii-of-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-to-begin-phase-iii-of-clinical-trials\/","title":{"rendered":"Cuba’s Abdala Vaccine to Begin Phase III of Clinical Trials"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

The Center for Genetic Engineering and Biotechnology will guarantee the doses needed for this clinical trial in which 42,000 people will take part.<\/h3>\n\n\n\n

Cuba’s President Miguel Diaz-Canel\u00a0on Saturday informed that the Abdala vaccine will start phase III of clinical trials this week in the provinces of Santiago de Cuba and Guantanamo.<\/p>\n\n\n\n

“We are one step closer to immunized all of our people,” the President tweeted and informed the vaccine will enter the last phase of trials after the Control of Medicines, Equipment, and Medical Devices Center (Cecmed) approves it.<\/p>\n\n\n\n

The Center for Genetic Engineering and Biotechnology (CIGB), which is developing the Abdala vaccine, and the AICA Laboratories company stated that they have guaranteed the doses needed for this clinical trial.<\/p>\n\n\n\n

“Everything is organized for the new phase to start smoothly,” CIGB stated as informed that 42,000 people will take part in the III phase.<\/p>\n\n\n\n

On February 25, CIGB and AICA Laboratories started the massive production of the Abdala vaccine, which will be applied intramuscularly.<\/p>\n\n\n\n

Cuba is also developing the Soberana 01, Soberana 01A, Soberana 02, and Mambisa COVID-19 vaccines. It will be one of the few countries worldwide to immunize its entire population with its drugs by 2021.<\/p>\n\n\n\n

Last week, Cecmed allowed the start of phase III clinical trials of Soberana 02, the first Cuban vaccine to enter the advanced phase of clinical trials.<\/p>\n\n\n\n

Source: Tele Sur<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Center for Genetic Engineering and Biotechnology will guarantee the doses needed for this clinical trial in which 42,000 people will take part. Cuba’s President Miguel Diaz-Canel\u00a0on Saturday informed […]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":3884,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[43],"tags":[],"class_list":["post-3883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":4712,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-proved-92-28-effective-in-last-stage-clinical-trials\/","url_meta":{"origin":3883,"position":0},"title":"Cuba’s Abdala vaccine proved 92.28% effective in last-stage clinical trials.","author":"Editorial Team","date":"June 22, 2021","format":false,"excerpt":"Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. \"Hit by the pandemic, our scientists\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5550,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-ships-15-million-abdala-vaccines-to-venezuela\/","url_meta":{"origin":3883,"position":1},"title":"Cuba Ships 1,5 Million Abdala Vaccines To Venezuela","author":"Editorial Team","date":"November 24, 2021","format":false,"excerpt":"\"We want to cooperate with the coronavirus immunisation of this brother country's people, who suffer the consequences of the U.S. blockade,\" Cuban scientists stated.\u00a0 On Saturday, Cuba's Center for Genetic Engineering and Biotechnology (CIGB) announced the delivery of 1,5 million Abdala COVID-19 vaccines to Venezuela. \"We want to cooperate with\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":4747,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/","url_meta":{"origin":3883,"position":2},"title":"Cuba’s Soberana 02 COVID-19 Vaccine To Reach 95% Efficiency","author":"Editorial Team","date":"June 27, 2021","format":false,"excerpt":"The\u00a0clinical trial's\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses. On Thursday, Cuba\u2019s Finlay Vaccine Institute announced that its Soberana 02 COVID-19 vaccine is most likely to reach\u00a0up to\u00a095 percent efficiency in third phase of clinical trials. FVI scientist Maria Toledo\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3251,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-has-four-vaccine-candidates-against-covid-19-on-clinical-trials\/","url_meta":{"origin":3883,"position":3},"title":"Cuba has four vaccine candidates against Covid-19 on clinical trials","author":"Editorial Team","date":"November 27, 2020","format":false,"excerpt":"Cuba has registered four vaccine candidates against Covid-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.According to information released on social networks, the regulatory entity of Medicines, Equipment and Medical Devices\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5590,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-bet-on-home-grown-covid-vaccines-is-paying-off\/","url_meta":{"origin":3883,"position":4},"title":"Cuba\u2019s bet on home-grown COVID vaccines is paying off","author":"Editorial Team","date":"November 30, 2021","format":false,"excerpt":"A health-care worker vaccinates a woman with the Abdala jab in August.Credit: Yamil Lage\/AFP via Getty Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials. When the COVID-19 pandemic began, Cuba decided not to wait on the rest of the world to develop\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4759,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-covid-vaccine-rivals-biontech-pfizer-moderna\/","url_meta":{"origin":3883,"position":5},"title":"Cuba’s COVID vaccine rivals BioNTech-Pfizer, Moderna","author":"Editorial Team","date":"June 30, 2021","format":false,"excerpt":"Cuba's health authorities said this week the domestically produced Abdala vaccine has proven to be 92% effective against the coronavirus in clinical trials. DW takes a closer look. In a measure of its ambitious efforts to be\u00a0vaccine self-reliant, Cuba has named one of its homegrown jabs Abdala, after a famous\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine-1.jpeg?fit=700%2C394&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine-1.jpeg?fit=700%2C394&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine-1.jpeg?fit=700%2C394&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine-1.jpeg?fit=700%2C394&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-10D","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=2304%2C1537&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=3883"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/3884"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=3883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=3883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=3883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}